Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial DINUP investigating a DPP-4 inhibitor plus narrow-band UV-B light for psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• DPP-4 inhibitor
• Narrow-band UV-B light therapy

Snippet

Sponsor: University College Dublin | Conditions: Psoriasis | Phase 2 | Status: COMPLETED